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PEPINE ET AL."2 have investigated the effects of perhexiline, 2-(2-dicyclohexyl ethyl) piperidine on angina in patients with coronary artery disease. They observed that the threshold to pacing-induced angina was increased, myocardial oxygen extraction was enhanced, and exerciseinduced angina was prevented, while myocardial function was not altered.' Coronary blood flow, measured as coronary sinus flow, was not altered. Previous investigations, using a canine preparation, suggested coronary vasodilatation as the mode of action of the drug.4 The demonstration of a significantly increased oxygen extraction in man suggested a mechanism analogous to that observed with propranolol,' rather than what one would anticipate from a coronary vasodilator drug.6 This suggested to us that the effects of perhexiline on coronary hemodynamics should be re-evaluated.
McGregor and Fam7 have suggested that the ideal antianginal drugs should constrict normally autoregulating areas of the myocardium and thereby facilitate collateral flow to ischemic regions. We investigated this mechanism of action by measuring coronary flow distribution using the radioactive microsphere technique. As we wished to evaluate the mechanism of action of the drug on normal and ischemic myocardium, we used the protocol suggested by Maroko et al. 8 of graded flow reduction to the point of ischemic myocardial failure.
Methods and Materials Preparation
Eight mongrel dogs with an average weight of 16 kg were anesthetized with sodium pentobarbital, intubated and ventilated using a Harvard respirator. A splenectomy was performed to maintain a constant hematocrit and oxygen was added to the respirator to maintain arterial PO2 above 80 mm Hg. Flow to the left coronary artery was controlled by establishing a coronary artery bypass circuit. A double lumen cannula was passed through the left carotid artery into the main stem of the left coronary artery. Through a left thoracotomy, a specially designed forcep was placed over the left main coronary artery which isolated this circulation from the systemic circulation. Before clamping the cannula in place, it was ascertained by injecting Evans blue dye and visually observing its distribution that flow distribution between the left anterior descending and circumflex branches of the coronary artery was even. Coronary flow was provided by shunting aortic blood through a heated (37°C) reservoir from which it was pumped by a Sarns 3500 calibrated pump. An air chamber was interposed between the pump and the coronary cannula to assure constant flow. A second nonoccluding metal cannula was placed in the mid portion of the coronary sinus to permit sampling of coronary venous blood. Along with lead II of the electrocardiogram, pressures were recorded at the tip of the coronary cannula, the aorta, left atrium and coronary sinus. These were recorded on a DR8 Electronics for Medicine recorder. The frequency response of the pressure recording system was flat up to 50 Hz.
Experimental Procedure
During the control period, coronary and aortic pressures were matched by changing pump flow. During this period, pressures were measured, aortic and coronary sinus blood samples were taken for measurement of pH, PCO2, PO2, oxygen content' and lactic acid.'0 The degree of reactive hyperemia present was tested by a 25 second flow arrest. We had previously determined that this duration of flow arrest induces a maximal decrease in coronary pressure with the restoration of control flow (unpublished observations). Also, regional myocardial blood flow was measured by injecting one of four types of microspheres* (1251, 14'Ce, 8"Sr, 95Nb) 15 ± 5 ,u in diameter directly into the coronary artery cannula over a period of 4-8 beats. Mixing of microspheres in the cannula was achieved by maintaining the velocity in the coronary cannula greater than 50 cm/sec. It was tested by determining that the concentration of microspheres was the same in the area of the left anterior descending as in the circumflex artery. As the bifurcation of these arteries occurs at the exit of the cannula it is unlikely that an even distribution of spheres would have occurred in the absence of adequate mixing.
Coronary blood flow was then abruptly reduced by 15 ml steps every 3 minutes until left atrial pressure increased indicating that ischemic failure of the left ventricle had occurred.8 During each step of flow reduction, samples were taken from the arterial and coronary sinus sites for measurement of oxygen content and lactic acid concentration.
As soon as left atrial pressure exceeded 10 mm Hg, pressures were measured, arterial and coronary sinus samples taken and regional myocardial blood flow measured. A period of flow arrest was performed to measure the degree of reactive hyperemia present. As soon as measurements were completed, coronary flow was returned to its control level. A 10 minute period of recovery followed.
Drug Administration
When pressures had returned to control, perhexiline maleatet was administered through a catheter in the pulmonary artery in a dose of 0.2 mg/kg/min for 10 minutes. Throughout the duration of administration, pressures were measured and arterial and coronary sinus samples obtained before and after drug administration. As the infusion of the drug with a constant coronary flow resulted in a marked increase in coronary pressure, two protocols were subsequently followed. In four studies, P3, P7, PlO and P22, coronary flow was set to the same level as in the previous control period. This resulted in a coronary perfusion pressure higher than control. In studies P13, P15, P16 and P21, coronary flow was reduced so that coronary pressure and aortic pressure were the same as control. In these instances, coronary flow was lower. Following 10 minutes, measurements were repeated. Then a graded flow reduction was repeated until left atrial pressure increased. Again, following graded flow reduction, measurement of coronary flow distribution and pressure was performed. At the end of the period of ischemia, pressures were restored to control and the animals sacrificed.
The perfusion volume of the left coronary artery was measured by injecting Evans blue dye in agar at control pressures and weighing the dyed myocardium. The heart was sliced into six transverse sections 8-10 mm thick. The dyed section was then divided into 6-8 wedges. Arteries and surrounding connective tissue were dissected free and then each wedge was divided into three layers of equal volume (epicardium, middle and endocardium). Approximately 100 separate pieces, constituting all of the myocardium perfused by the left coronary system, were processed for each study. Each piece was then weighed on an analytical balance and counted using a Beckman biogamma counter. Sufficient counts were collected to provide a standard deviation of less than 2%. Counting data were processed using a computer program which corrected for isotope spill and decay and yielded flow per gram (f) according to the formula: f= F * c/D where F is pump flow, c is counts per gram and D is total counts for an isotope for the whole heart. Regional flow was calculated as the average flow of the approximately 30 pieces in a region. Total flow was calculated by dividing pump flow by the mass of tissue perfused by the cannula. Statistical analysis of the data was performed according to the method of Snedecor and Cochran." Values are presented as means and standard error. Results
Effects of Graded Flow Reduction
Hemodynamics (table J, fig. 1 )
The consequence of a graded reduction in coronary flow are presented in table 1. Coronary flow was reduced from 117.6 ± 8.4 ml/100 g/min to 27.0 ± 4.7 which resulted in coronary systolic pressure decreasing from 123 ± 8.2 mm Hg to 44.0 ± 2.8 and coronary diastolic pressure from 87.9 ± 6.3 to 25.4 + 2.2 mm Hg. Aortic pressure decreased less than did coronary pressure, from 116.6 ± 7.2/84.4 ± 6.8 to 67.6 ± 5.3/41.9 ± 3.2 mm Hg. Left atrial pressure, our indicator of ischemic depression of myocardial function, increased from 6.6 0.5 to 11.4 ± 1.1 mm Hg. Heart rate decreased from 152 i 5 to 129 ± 11. This decrease was not significant. (table 1) Associated with a reduction of coronary flow, epicardial, mid-zone and endocardial flow decreased. Endocardial blood flow was significantly lower than epicardial (P < 0.001). The measured endo/epicardial flow ratio fell from 0.97 ± 0.06 to 0.41 ± 0.07 (P < 0.001).
Coronary Flow Distribution
Myocardial Oxygen Consumption (table 3) Decreasing coronary blood flow decreased myocardial oxygen consumption.
Myocardial Lactate Balance (fig. 2) Only one instance of myocardial lactate output was observed during our study and this was during a control observation. Decreasing coronary blood flow tended to decrease lactate uptake but this relationship was not statistically significant.
II. Acute Effects of Drug Administration (table 2) The infusion of the drug into the pulmonary artery had no effect on heart rate, aortic pressure or left atrial pressure. A marked increase in coronary systolic and diastolic pressure was observed while coronary flow was kept constant (coronary diastolic pressure increased significantly, P < 0.02), implying an increase in coronary resistance. Associated with the increase in coronary artery pressure myocardial oxygen uptake tended to increase (not significant). 
Hemodynamics
Total coronary flow was slightly lower for the group after perhexiline (97.9 ± 9.7 compared with 117.6 ± 8.4 ml/l00 g/min before drug) as a consequence of decreased flow in four studies. Coronary pressure was slightly reduced from 123.0 ± 8.2/87.9 ± 6.3 to 118 ± 10.5/77.8 ± 7.7 mm Hg. Left atrial pressures were similar. Heart rate was 139 ± 6 beats per minute, significantly lower than 152 ± 5 (P < 0.02). (table 1) Associated with a lower total coronary flow, epi, mid-zone and endocardial flow also decreased. Epicardial flow reduction of 0.24 ml/g/min was significant (P < 0.001). The endo:epi ratio increased from 0.97 ± 0.06 to 1.10 ± 0.14 (NS).
Coronary Flow Distribution

IV. Graded Flow Reduction Following Perhexiline
Hemodynamics (table I fig. 1) Following perhexiline, after ischemia for the same coronary flow, coronary pressure was higher, 48. Myocardial Oxygen Consumption (table 3) Following perhexiline administration at the same coronary blood flow, myocardial oxygen consumption decreased. This decrease averaged 0.86 ± 0.35 ml/ 100 g/min and, as paired differences, was significant (P < 0.02).
Myocardial Lactate Balance (fig. 2) Following administration of the drug during graded flow reduction, lactate uptake at a specific coronary flow increased +0.17 ± 0.07 ,tM/100 g/min which, when analyzed as paired differences, was a significant increase (P < 0.05). Over the course of flows studied, lactate uptake decreased as coronary flow decreased in a linear fashion and could be described by the equation y (lactate uptake in ,uM/100 g/min) = .005x (coronary flow) + .091 (r = 0.46, F = 3.94).
Discussion
Perhexiline appears to act by redistributing a limited coronary blood flow preferentially to the endocardium. This action appears to be independent of autoregulation as it persisted when autoregulation had apparently been abolished by ischemia. Associated with this redistribution, myocardial oxygen consumption was reduced and lactate utilization enhanced in the presence of reduced flow.
McGregor and Fam7 proposed that the mode of action of the ideal antianginal drug would be to redistribute myocardial blood flow. This hypothesis resulted from the observations of Fam and McGregor' on dipyridamole, a potent coronary vasodilator with disappointing properties as an antianginal agent. They subsequently showed that nitroglycerin, an effective agent, acted on the coronary circulation to dilate epicardial capacitance vessels with little effect upon transmural coronary resistance. Becker et al.," using the microsphere technique, showed that in the dog myocardium, ischemia reduced endocardial blood flow which was partially reversed by the administration of propranolol or nitroglycerin. Winbury" postulated that nitrates act to dilate resistance vessels leading from the epicardium to the endocardium and that the vascular response of these vessels was independent of autoregulation. Perhexiline appears to have a similar mode of action which may be common to many antianginal drugs."4 Buckberg et al."' have proposed that the transmural distribution of coronary blood flow is determined by the ratio of diastolic pressure time divided by systolic pressure time and by autoregulation. Work from this laboratory (unpublished observations) has suggested that the determinant of transmural distribution is the ratio of coronary diastolic pressure to left ventricular systolic pressure and left ventricular diastolic pressure and that this distribution is independent of autoregulation. We examined these indices of distribution and found that the action of perhexiline to change the endo:epi ratio appears to be independent of both pressures, pressure time and autoregulation.
As part of McGregor's hypothesis7 he proposed that antianginal drugs would affect the normal autoregulatory areas increasing their tone thus increasing the pressure gradient favoring collateral flow to ischemic regions. Perhexiline appears to do this acutely as indicated by the abrupt rise in coronary perfusion pressure at a constant coronary flow while the drug was being administered. This effect is similar to the one detected by Becker et al. 12 during ischemia from propranolol.
The mechanism by which myocardial oxygen consumption was reduced by perhexiline is uncertain. The usual determinants of oxygen consumption, systemic pressure and heart rate, were similar. It is possible that associated with improved endocardial blood flow less ventricular dilatation occurred with ischemia or myocardial efficiency was improved. We did not observe net myocardial lactate production during the graded myocardial flow reduction as was observed by Case et al. '6 Presumably this related to the duration of flow reduction used. Nevertheless the decrease in flow was sufficient to increase left atrial pressure and to reduce coronary sinus oxygen content. Lactate utilization was reduced as coronary flow decreased. Perhexiline acted to increase myocardial lactate utilization above control levels which suggests that ischemic induced stimulation of glycolysis was less following perhexiline and that oxidative metabolism was enhanced in the presence of a decreased myocardial oxygen consumption. It is possible that perhexiline has a direct effect on intermediary metabolism. It is of interest that while the drug acted to increase lactate uptake during graded flow reduction, it did not alter the effect of flow reduction on left atrial pressure. This suggests a dissociation between metabolic and mechanical consequences of ischemia.
Many of the actions of this agent are similar to those which have been observed to occur from the administration of the beta blocking drug, propranolol. That is,-it increases coronary vascular resistance,'3 it decreases myocardial oxygen consumption' and it decreases lactate output.'7 However, other investigations suggest that it does not have beta blocking properties.' It also appears to have properties similar to nitrates in its ability to redistribute myocardial blood flow. 12 
